Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 6Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia 3Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Hematologic Neoplasms 2Anemia, Aplastic 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Metabolic Diseases 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Immunologic Deficiency Syndromes 1Hematologic Diseases 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 25Tacrolimus 17fludarabine phosphate 14Mycophenolic Acid 14Antilymphocyte Serum 13Cyclosporine 12Methylprednisolone 11Methotrexate 11Melphalan 11Busulfan 11fludarabine 10Radiotherapy 10Peripheral Blood Stem Cell Transplantation 10Filgrastim 10Whole-Body Irradiation 9Sirolimus 9Etoposide 5Therapeutics 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4Alemtuzumab 4thymoglobulin 3Stem Cell Transplantation 3Rituximab 3Prednisone 3Hematopoietic Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Cyclosporins 3Amplified Fragment Length Polymorphism Analysis 3Leucovorin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Mesna × Plasma cell × Clear all
NCT00473551 2011-12-19

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡